Strategic investment in 15 promising technologies could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events.
At the latest meeting in a series of international biosecurity dialogues hosted by the Center for Health Security, conversations on scientific and policy issues related to South Asia followed a pragmatic theme: infectious disease outbreaks are inevitable, pandemics are optional.
Investments in global health security programs at the federal level directly benefit US national security and the economy by helping to prevent the cross-border spread of infectious disease outbreaks in other countries.
Biosecurity risks to Southeast Asia stem from the region’s highly dynamic human-animal-environmental interface, a growing threat from terrorist groups, and the increased prevalence of advanced biotechnology.
Remarks delivered by Gigi Gronvall, PhD, on August 9, 2018, at the Meeting of Experts on Review of developments in the field of science and technology related to the United Nations Biological Weapons Convention.
Faculty at the Center for Health Security have developed a new degree track at the Johns Hopkins Bloomberg School of Public Health for US and international students who are passionate about taking a leadership role in preventing, detecting, and responding to epidemics and other disasters.
Crystal Watson, DrPH, has been accepted into the Council on Foreign Relations Stephen M. Kellen Term Member Program, which offers promising young leaders the opportunity to participate in a sustained conversation on international affairs and US foreign policy.
Effective communication is vital to ensuring people’s safety during all types of public health emergencies—from Ebola and Zika to hurricanes and wildfires.
The outbreak of a moderately contagious and moderately lethal novel pathogen precipitated a catastrophic end to the scenario in Clade X, the day-long pandemic tabletop exercise hosted by the Center for Health Security on May 15.
Infectious disease preparedness work focuses predominantly on an historical list of pathogens derived from biological warfare agents, political considerations, and recent outbreaks.
